e-Drug3D

1442

DIFLUPREDNATE

INN
DIFLUPREDNATE

(has an active metabolite)

cas 23674-86-4

CLASS

DERMATOLOGICALS
ANTIINFLAMMATORY
TOPICAL CORTICOSTEROID
AGONIST

ROUTE (list)

OPHTHALMIC

ATC code

D07AC19
S01BA16

PK parameters

Target

TARGET GLUCOCORTICOID RECEPTOR

DrugCentral

Glucocorticoid receptor UNIPROT P04150 NR3C1

Download SDF file

Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-6,9-difluoro-11-hydroxy-17-(1-oxobutoxy)-, (6.alpha.,11.beta.)-

Formula:
C27H34F2O7

Calculated chemical properties:

MW 508.54
NB_atoms 36
XLogP 3.52
PSA 93.344
NB_HD 1
NB_HA 7
fsp3 0.70
Lipinski(0=no;1=yes) 0

FDA
NDA 022212 (label) INN (DIFLUPREDNATE) DUREZOL (SANDOZ) APPROVAL= AP YEAR= 2008 NEWMOLECULARENTITY
NDA 211526 (pdf not found) INN (DIFLUPREDNATE) DIFLUPREDNATE (AMNEAL) APPROVAL= AP YEAR= 2021
NDA 211776 (pdf not found) INN (DIFLUPREDNATE) DIFLUPREDNATE (CIPLA) APPROVAL= AP YEAR= 2021
NDA 214894 (pdf not found) INN (DIFLUPREDNATE) DIFLUPREDNATE (DR REDDYS) APPROVAL= AP YEAR= 2022
NDA 207284 (pdf not found) INN (DIFLUPREDNATE) DIFLUPREDNATE (EPIC PHARMA LLC) APPROVAL= AP YEAR= 2024
NDA 219441 (pdf not found) INN (DIFLUPREDNATE) DIFLUPREDNATE (CAPLIN) APPROVAL= AP YEAR= 2024
NDA 212566 (pdf not found) INN (DIFLUPREDNATE) DIFLUPREDNATE (MYLAN LABS LTD) APPROVAL= AP YEAR= 2025
NDA 218191 (pdf not found) INN (DIFLUPREDNATE) DIFLUPREDNATE (UPSHER SMITH LABS) APPROVAL= AP YEAR= 2025
NDA 213774 (pdf not found) INN (DIFLUPREDNATE) DIFLUPREDNATE (ALEMBIC) APPROVAL= AP YEAR= 2026